Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Gustavo Pesquin
Equibles does not estimate personal net worth.
Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMRX alertsAbout Gustavo Pesquin
Amneal Pharmaceuticals, Inc. reported in an 8-K filed September 6, 2022 that Gustavo Pesquin was appointed Executive Vice President, Chief Commercial Officer – Specialty, effective September 6, 2022. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.
“Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced it has appointed Gustavo Pesquin as Executive Vice President, Chief Commercial Officer - Specialty, effective September 6, 2022.”
Affiliation history
-
Current
2022-09-06–present
Company network
Leadership on record at Amneal Pharmaceuticals, Inc.
- Chintu Patel CEO, Board Member
- Chirag Patel CEO, Board Member
- Paul Meister Chairman, Board Member
- Anastasios (Tasos) G. Konidaris CFO
- Anastasios Konidaris CFO
- Stephen J. Manzano General Counsel
- Deb Autor Board Member
- Deborah M. Autor Board Member
- Gautam Patel Board Member
- J. Kevin Buchi Board Member